| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 8e-05 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 7.7e-05 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 5.3e-05 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 4.9e-05 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 4.1e-05 | 1 |